SAT-3247

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsNCT07287189MSLEPhase 2Active not recruiting2027-03-31Estimated
An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101NCT06867107MSLEPhase 2Recruiting2027-09-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.